✨ Veterinary Medicine Notices
NEW ZEALAND GAZETTE, No. 86 — 29 SEPTEMBER 2016
General Use Claim:
For use in cattle for the anti-inflammatory, analgesic and anti-pyretic treatment of: acute mastitis, mammary oedema, respiratory conditions, colic, musculoskeletal conditions.
For use in horses for the anti-inflammatory and analgesic treatment of musculoskeletal disorders, symptomatic analgesic treatment of colic, and treatment of fever.
For use in pigs for reduction of pyrexia in cases of respiratory disease and Postpartum Dysgalactia Syndrome (Metritis, Mastitis, Agalactia syndrome) in sows, in combination with antimicrobial therapy, where appropriate.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
a. must state in full the reasons for making the submission; and
b. may state any decision sought on that application; and
c. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
a. where submissions on this application are to be sent; and
b. where requests for copies of the public information relating to the application can be sent; and
c. where public information relating to the application can be viewed; and
d. the director-general’s address for service:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
AgriHealth NZ Limited, Unit 1.2, 89 Grafton Road, Grafton, Auckland 1010.
Dated at Wellington this 27th day of September 2016.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).
Notice of Reassessment of Registered Trade Name Product (Notice No. MPI 691)
Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that the following application has been made to reassess the following trade name product under section 29 of the Act:
Trade Name: Apivar
Reference: P005702
Active Ingredient and Concentration:
Amitraz 33g/kg (500mg per strip)
Formulation Type: Vapour releasing product
General Use Claim:
For the control of mites (varroatosis) on honey bees.
The purpose of the reassessment is to evaluate new information on residues which may impact the current New Zealand Maximum Residue Level for amitraz in honey, and to review the controls and approvals in place for the registered product.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
63
Next Page →
NZ Gazette 2016, No 86
✨ LLM interpretation of page content
🌾 General Use Claim for Veterinary Medicine
🌾 Primary Industries & Resources27 September 2016
Veterinary Medicine, Anti-inflammatory, Analgesic, Cattle, Horses, Pigs
- MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries
🌾 Notice of Reassessment of Registered Trade Name Product
🌾 Primary Industries & ResourcesTrade Name Reassessment, Agricultural Compounds, Veterinary Medicines, Apivar, Amitraz
- Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries